CRISPR Therapeutics
CRSP
$55.48
Share price
-2.59%
Change (1 day)
-15.87%
Change (1 year)
Earnings for CRISPR Therapeutics (CRSP)
Earnings in 2023 (TTM): -$0.16 B
According to CRISPR Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.16 B. In 2022 the company made an earning of -$0.66 B a decrease over its 2021 earnings that were of $0.37 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for CRISPR Therapeutics from 2016 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.16 B | -76.83% |
| 2022 | -$0.66 B | -271.4% |
| 2021 | $0.37 B | -209.04% |
| 2020 | -$0.35 B | -617.12% |
| 2019 | $67.3 M | -140.93% |
| 2018 | -$0.17 B | 146.86% |
| 2017 | -$66.61 M | 193.19% |
| 2016 | -$22.72 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -26.50% | 🇺🇸 USA |